These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17105223)

  • 41. Characterization of mycoplasma arginine deiminase expressed in E. coli and its inhibitory regulation of nitric oxide synthesis.
    Noh EJ; Kang SW; Shin YJ; Kim DC; Park IS; Kim MY; Chun BG; Min BH
    Mol Cells; 2002 Feb; 13(1):137-43. PubMed ID: 11911465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-assembling nanocomposites for protein delivery: supramolecular interactions between PEG-cholane and rh-G-CSF.
    Salmaso S; Bersani S; Mastrotto F; Tonon G; Schrepfer R; Genovese S; Caliceti P
    J Control Release; 2012 Aug; 162(1):176-84. PubMed ID: 22727711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification and characterization of arginine deiminase from Pseudomonas putida: Structural insights of the differential affinities of l-arginine analogues.
    Patil MD; Rathod VP; Bihade UR; Banerjee UC
    J Biosci Bioeng; 2019 Feb; 127(2):129-137. PubMed ID: 30143336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.
    Han RZ; Xu GC; Dong JJ; Ni Y
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):4747-60. PubMed ID: 27087524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin.
    Savaraj N; Wu C; Li YY; Wangpaichitr M; You M; Bomalaski J; He W; Kuo MT; Feun LG
    Oncotarget; 2015 Mar; 6(8):6295-309. PubMed ID: 25749046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arginine Deiminase: Current Understanding and Applications.
    Zarei M; Rahbar MR; Morowvat MH; Nezafat N; Negahdaripour M; Berenjian A; Ghasemi Y
    Recent Pat Biotechnol; 2019; 13(2):124-136. PubMed ID: 30569861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational surface engineering of an arginine deiminase (an antitumor enzyme) for increased PEGylation efficiency.
    Cheng F; Yang J; Schwaneberg U; Zhu L
    Biotechnol Bioeng; 2019 Sep; 116(9):2156-2166. PubMed ID: 31062871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inactivation of microbial arginine deiminases by L-canavanine.
    Li L; Li Z; Chen D; Lu X; Feng X; Wright EC; Solberg NO; Dunaway-Mariano D; Mariano PS; Galkin A; Kulakova L; Herzberg O; Green-Church KB; Zhang L
    J Am Chem Soc; 2008 Feb; 130(6):1918-31. PubMed ID: 18205354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo.
    Miraki-Moud F; Ghazaly E; Ariza-McNaughton L; Hodby KA; Clear A; Anjos-Afonso F; Liapis K; Grantham M; Sohrabi F; Cavenagh J; Bomalaski JS; Gribben JG; Szlosarek PW; Bonnet D; Taussig DC
    Blood; 2015 Jun; 125(26):4060-8. PubMed ID: 25896651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.
    McAlpine JA; Lu HT; Wu KC; Knowles SK; Thomson JA
    BMC Cancer; 2014 Aug; 14():621. PubMed ID: 25164070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis.
    Izzo F; Montella M; Orlando AP; Nasti G; Beneduce G; Castello G; Cremona F; Ensor CM; Holtzberg FW; Bomalaski JS; Clark MA; Curley SA; Orlando R; Scordino F; Korba BE
    J Gastroenterol Hepatol; 2007 Jan; 22(1):86-91. PubMed ID: 17201887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Directed evolution of an antitumor drug (arginine deiminase PpADI) for increased activity at physiological pH.
    Zhu L; Tee KL; Roccatano D; Sonmez B; Ni Y; Sun ZH; Schwaneberg U
    Chembiochem; 2010 Mar; 11(5):691-7. PubMed ID: 20157910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin.
    Thomas JB; Holtsberg FW; Ensor CM; Bomalaski JS; Clark MA
    Biochem J; 2002 May; 363(Pt 3):581-7. PubMed ID: 11964159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs.
    Nguyen J; Xie X; Neu M; Dumitrascu R; Reul R; Sitterberg J; Bakowsky U; Schermuly R; Fink L; Schmehl T; Gessler T; Seeger W; Kissel T
    J Gene Med; 2008 Nov; 10(11):1236-46. PubMed ID: 18780309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells.
    Kang SW; Kang H; Park IS; Choi SH; Shin KH; Chun YS; Chun BG; Min BH
    Mol Cells; 2000 Jun; 10(3):331-7. PubMed ID: 10901172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase.
    Yoon CY; Shim YJ; Kim EH; Lee JH; Won NH; Kim JH; Park IS; Yoon DK; Min BH
    Int J Cancer; 2007 Feb; 120(4):897-905. PubMed ID: 17096330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arginine deiminase uses an active-site cysteine in nucleophilic catalysis of L-arginine hydrolysis.
    Lu X; Galkin A; Herzberg O; Dunaway-Mariano D
    J Am Chem Soc; 2004 May; 126(17):5374-5. PubMed ID: 15113205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
    Ott PA; Carvajal RD; Pandit-Taskar N; Jungbluth AA; Hoffman EW; Wu BW; Bomalaski JS; Venhaus R; Pan L; Old LJ; Pavlick AC; Wolchok JD
    Invest New Drugs; 2013 Apr; 31(2):425-34. PubMed ID: 22864522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermostability of native and pegylated Myceliophthora thermophila laccase in aqueous and mixed solvents.
    López-Cruz JI; Viniegra-Gonzalez G; Hernández-Arana A
    Bioconjug Chem; 2006; 17(4):1093-8. PubMed ID: 16848420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer.
    Chung SF; Kim CF; Kwok SY; Tam SY; Chen YW; Chong HC; Leung SL; So PK; Wong KY; Leung YC; Lo WH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.